An opportunity to broaden your horizon on the latest and hottest industry trends that shape the pharmaceutical landscape.
The CPhI Pre-Connect Congress, which starts a day before the show, is a great opportunity to broaden your horizon on the latest and hottest industry trends that shape the pharmaceutical landscape.
This event is attended by industry experts and senior executives from all the various segments of the pharmaceutical industry, from those involved in small molecules and biologics, as well as generic drugs and biosimilars, to excipients and advanced drug delivery technologies.
There will be a commercial track and a technical track, with eight modules to choose from—API sourcing in emerging markets; excipients & formulation; strategic alliance & partnering; drug delivery systems & technology; generics & supergenerics; biopharmaceuticals; biosimilars & biobetters; and new trends in oncology.
Presentations and discussions will focus on the supply chain security of starting materials in light of new regulations; market opportunities in Brazil, China, and India; the changing dynamics of outsourcing and key considerations for creating successful partnerships; how to achieve multifunctional performance of next generation excipients; approaches to overcome bioavailability challenges and achieve optimal delivery profile for better patient outcomes; and perspectives on the global generic drug market, amongst others.
The Pre-Connect Congress will take place at the same location as CPhI Worldwide, at Paris Nord Villepinte, France, on October 6. More information, including registration details, can be found here.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.